home
portfolio
team
careers
contact
investor portal
home
portfolio
team
careers
contact
investor portal
Nextech Invest
Kinnate Biopharma Inc. Reports First Quarter 2022 Financial Results and Provides Operational Updates
Kinnate Biopharma Inc. Reports First Quarter 2022 Financial Results and Provides Operational Updates
Post navigation
Previous Post
Previous
Kronos Bio’s Investigational SYK Inhibitors Entospletinib and Lanraplenib to be Featured in Four Poster Presentations at EHA2022 Congress
Next Post
Next
Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update